海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
219件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- A 12 Week study to assess Safety & efficacy of QAW039 when added to standard of care in patients with uncontrolled asthma
- Moderate persistent asthma
- Argentina, Canada, Czech Republic, Greece, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Panama, Russian Federation, Serbia, Slovakia, South Africa, Spain, Taiwan, United States of America
- 2018-06-15
Recruiting
- Study of the therapeutic effect of an added gel with Pequi Oil on the functionality of patients with knee osteoarthritis.
- Gonarthrosis. M17 C05.550;M00-M99;C05.550
- Brazil
- 2018-04-29
Not Recruiting
- SR-PAAS - Sitaxentan Efficacy and Safety Trial With a Randomized Prospective Assessment of Adding Sildenafil
- Pulmonary Arterial Hypertension
- Argentina, Bulgaria, Chile, China, Colombia, Costa Rica, Czech Republic, Dominican Republic, Guatemala, India, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, South Africa, Thailand, Turkey, Ukraine, United States of America
- 2009-05-13
Not recruiting
- Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
- Type 2 Diabetes Mellitus
- Argentina, Australia, Brazil, Canada, Chile, India, Mexico, Peru, Philippines, Russian Federation, Taiwan, Thailand, Ukraine, United States
- 2005-03-31
Not recruiting
- Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
- Pulmonary Arterial Hypertension;Pulmonary Hypertension;Pulmonary Arterial Hypertension;Pulmonary Hypertension;Pulmonary Arterial Hypertension;Pulmonary Hypertension;Pulmonary Arterial Hypertension;Pulmonary Hypertension
- Argentina, Bulgaria, Chile, China, Colombia, Costa Rica, Czech Republic, Dominican Republic, Egypt, Guatemala, India, Jordan, Lebanon, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, South Africa, Thailand, Turkey, Ukraine, United Arab Emirates, United States
- 2008-11-20
Not recruiting
- A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)
- Hypercholesterolemia
- Brazil, China, Korea, Republic of, Mexico, Russian Federation, Taiwan, Turkey
- 2013-05-20
Not Recruiting
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-MASKED STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF SHP640 (PVP-IODINE 0.6% AND DEXAMETHASONE 0.1%) OPHTHALMIC SUSPENSION COMPARED TO PVP-IODINE AND PLACEBO IN THE TREATMENT OF ADENOVIRAL CONJUNCTIVITIS.
- -B301 +Conjunctivitis due to adenovirus (H13.1*) +Conjunctivitis due to adenovirus (H13.1*);+Conjunctivitis due to adenovirus (H13.1*)
- Australia, Austria, Canada, Colombia, Estonia, France, Germany, Hungary, India, Israel, Italy, Philippines, Poland, South Africa, Spain, United Kindgdom, United States
- 2018-08-13
Authorised
- This is a study to help understand how Baricitinib compares to placebo (a tablet that does not contain any active medicine) in adults with moderate to severe atopic dermatitis, also known as atopic eczema
- Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Argentina, Australia, Austria, Hungary, Israel, Japan, Korea, Republic of, Poland, Spain, Switzerland
- 2017-10-05
Recruiting
- Global cross-sectional burden-of-illness study in adolescent and adult patients with atopic dermatitis (MEASURE-AD)
- ;L20-L30 - Dermatitis and eczema
- Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Kuwait, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Saudi Arabia, Slovakia, Spain, Switzerland, Taiwan, Province of China, Turkey, United Arab Emirates
- 2020-01-21
Not Recruiting
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
- Rheumatoid Arthritis MedDRA version: 16.1 Level: PT Classification code 10039073 Term: Rheumatoid arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Argentina, Belgium, Brazil, Colombia, Czech Republic, Estonia, Finland, Hungary, Israel, Italy, Mexico, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom, United States
- 2013-01-03
